Richard A. Hansen
Affiliations: | Pharmaceutical Sciences | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pharmacy, EpidemiologyGoogle:
"Richard Hansen"Children
Sign in to add trainee| Stacie B. Dusetzina | grad student | 2010 | UNC Chapel Hill |
| Brian Leinwand | grad student | 2011 | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dusetzina SB, Sarpatwari A, Carrier MA, et al. (2022) Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D. Jama Internal Medicine. 181: 1605-1611 |
| Chou C, McDaniel CC, Abrams JD, et al. (2020) An Examination of Prescribing Responsibilities between Psychiatrists and Primary Care Providers. The Psychiatric Quarterly |
| Chen L, Li C, Huo N, et al. (2020) Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study. Current Medical Research and Opinion. 1 |
| Potthoff K, Stötzer O, Söling U, et al. (2020) Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO. Clinical Breast Cancer. 20 |
| Rahman MM, Howard G, Qian J, et al. (2020) Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study. Research in Social & Administrative Pharmacy : Rsap |
| Hohmann NS, Garza KB, Surry D, et al. (2019) Healthcare provider opinions about a generic drug educational newsletter: A pilot cross-sectional survey. Research in Social & Administrative Pharmacy : Rsap |
| Lin YT, Lu TS, Hansen RA, et al. (2019) Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study. Clinical Therapeutics. 41: 1128-1138.e8 |
| Hohmann NS, Garza KB, Surry D, et al. (2019) Communicating benefits and risks of generic drugs to consumers: Patient and caregiver opinions of two FDA-developed educational materials. Research in Social & Administrative Pharmacy : Rsap |
| Fahim SM, Mishuk AU, Cheng N, et al. (2018) Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion On Drug Safety |
| Hohmann N, Hansen R, Garza KB, et al. (2018) Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 1186-1191 |